This article is more than 5 years old. Information may no longer be current.
Newly inducted ASCRS Hall of Famer calls for continued research into IOL pathology
Click Here to Manage Email Alerts
SAN DIEGO — David J. Apple, MD, called for an infusion of new energy into research on intraocular lens pathology, upon being recognized yesterday as the newest inductee of the American Society of Cataract and Refractive Surgery's Ophthalmology Hall of Fame.
|
"Who will take over when I retire or die?," Dr. Apple asked during the opening session of the annual meeting of ASCRS.
Incoming ASCRS president Richard L. Lindstrom, MD, pointed out Dr. Apple's more than 20 years of research and called him a "true pioneer" in the study of IOL pathology, including his breakthrough study that showed the ideal placement of early IOLs to avoid posterior capsular opacification.
Dr. Apple, who trained under Lorenz E. Zimmerman, MD, and was a devoted admirer of the work of Sir Harold Ridley, MD, recently celebrated the 25th anniversary of his own "Apple Korps" of trainees.
Still, he voiced concerns over not having a true successor to continue studying the pathological implications of the constantly evolving IOL technologies, both current and future designs.
"I want this to keep going and not be stagnant and die," said Dr. Apple, who received a standing ovation for his work.